[1
]
Department of Pharmacotherapy, College of Pharmacy, University of Utah, Salt Lake
City, UT, USA. stene032@d.umn.edu.
[2
]
Department of Pharmacy Practice and Pharmaceutical Sciences, College of Pharmacy,
University of Minnesota, 1110 Kirby Drive, 232 Life Science, Duluth, MN, 55812, USA.
stene032@d.umn.edu.
[3
]
AstraZeneca Pharmaceuticals, Gaithersburg, MD, USA.
[4
]
GlaxoSmithKline, 5 Moore Drive, Research Triangle Park, NC, 27709, USA.
[5
]
Department of Pharmacotherapy, College of Pharmacy, University of Utah, Salt Lake
City, UT, USA.
[6
]
Daiichi-Sankyo, Basking Ridge, NJ, USA.
[7
]
Truven Health, Ann Arbor, MN, USA.
[8
]
University of Southern California, San Diego, CA, USA.
[9
]
Division of Pharmaceutical Outcomes and Policy, Eshelman School of Pharmacy, University
of North Carolina, Chapel Hill, NC, USA.
[10
]
Amgen Inc, Thousand Oaks, CA, 91320, USA.
[11
]
RTI Health Solutions, Barcelona, Spain.
[12
]
RTI Health Solutions, Waltham, MA, USA.
[13
]
AbbVie Inc, Pharmacovigilance and Patient Safety, North Chicago, IL, USA.